Hap Trading, LLC Prometheus Biosciences, Inc. Transaction History
Hap Trading, LLC
- $872 Billion
- Q3 2024
A detailed history of Hap Trading, LLC transactions in Prometheus Biosciences, Inc. stock. As of the latest transaction made, Hap Trading, LLC holds 30,400 shares of RXDX stock, worth $0. This represents 0.01% of its overall portfolio holdings.
Number of Shares
30,400Holding current value
$0% of portfolio
0.01%Shares
0 transactions
Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
---|
Others Institutions Holding RXDX
# of Institutions
2Shares Held
29.6KCall Options Held
0Put Options Held
0About Prometheus Biosciences, Inc.
- Ticker RXDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,904,100
- Description
- Prometheus Biosciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel therapeutics and companion diagnostics products for the treatment of inflammatory bowel diseases (IBD). Its lead product includes PRA023, a humanized IgG1 monoclonal antibody (mAb), which is in Phase IIa clinical trial...